rs1555580427
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000135.4(FANCA):c.163C>T(p.Gln55*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,686 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000135.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Fanconi anemia complementation group AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000135.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FANCA | NM_000135.4 | MANE Select | c.163C>T | p.Gln55* | stop_gained | Exon 2 of 43 | NP_000126.2 | ||
| FANCA | NM_001286167.3 | c.163C>T | p.Gln55* | stop_gained | Exon 2 of 43 | NP_001273096.1 | |||
| FANCA | NM_001018112.3 | c.163C>T | p.Gln55* | stop_gained | Exon 2 of 11 | NP_001018122.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FANCA | ENST00000389301.8 | TSL:1 MANE Select | c.163C>T | p.Gln55* | stop_gained | Exon 2 of 43 | ENSP00000373952.3 | ||
| FANCA | ENST00000563673.5 | TSL:1 | c.163C>T | p.Gln55* | stop_gained | Exon 2 of 10 | ENSP00000456443.1 | ||
| FANCA | ENST00000534992.5 | TSL:1 | c.163C>T | p.Gln55* | stop_gained | Exon 2 of 11 | ENSP00000443675.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461686Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727162 show subpopulations
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Fanconi anemia complementation group A Pathogenic:2
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
Fanconi anemia Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in FANCA are known to be pathogenic (PMID: 19367192). This variant has been observed in individual(s) with Fanconi anemia (PMID: 10094191, 26799702). ClinVar contains an entry for this variant (Variation ID: 550581). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gln55*) in the FANCA gene. It is expected to result in an absent or disrupted protein product.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at